Over the past five years, Eli Lilly stock has risen roughly 320% as of market close Aug. 11. Meanwhile, the company has ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Eli Lilly had profit of $10 billion in 2024. It could afford its Wisconsin project without Evers' $100 million tax credits ...

The obesity market still only has two clear leaders with approved GLP-1 medications, and frontrunners Eli Lilly and Novo ...

Shares of Eli Lilly (NYSE: LLY), the pharmaceuticals giant and maker of the Mounjaro and Zepbound weight loss drugs, saw its ...

The UK government will contribute up to £50 million of new investment into the scheme, with Lilly contributing up to £35 ...

This will be the first time the option has been taken up since it was introduced at the beginning of 2025, under the Medical ...

Eli Lilly's experimental oral pill, orforglipron, shows promise in obesity treatment, with participants experiencing an ...

Lilly Ghalichi is a lawyer-turned-beauty mogul and entrepreneur, as well as the CEO and Founder of Lilly Lashes—a brand worn ...

Leaders at Eli Lilly believe heavy investment in the company's manufacturing footprint “sets a high standard that newcomers ...

Kinder Morgan benefits from this through a massive $9.3 billion backlog, with $1.3 billion in new projects added and $750 ...

Eli Lilly and Company and the UK Government have announced a joint programme to develop innovative models of care for obesity ...